Health & Pharm

May 30, 2012

Alerts Login

Asian Activities Report for January 9, 2012: Little Sheep Group (HKG:0968) Shareholders Approved Yum! Brands (NYSE:YUM) Takeover Offer

2012/01/09  13:00 - Asian Activities Report for January 9, 2012 includes: Little Sheep Group Limited (HKG:0968) says that its shareholders have approved the proposed acquisition of Little Sheep Group by Yum! Brands, Inc. (NYSE:YUM); Sinopec Kantons Holdings Limited (HKG:0934) has signed agreements to acquire 50% interest in Fujairah Oil Terminal United Arab Emirates from Concord HK; Hitachi, Ltd (NYSE:HIT) (TYO:6510) says that it expects to close the transaction of transferring its hard disk drive business to Western Digital Corporation (NYSE:WDC) by March 2012; Japanese software developer Celartem Technology Inc. (JASDAQ:4330) has signed a contract to participate in a smart micro grid project at the Beijing New Energy Industry Base; Takeda Pharmaceutical Company Limited (TYO:4502) says that it will work with Osaka University to develop a platform for practical application and commercialization of nano-particle vaccines.

Wincor Nixdorf's (FRA:WIN) 100,000 Self-Service Devices On Five Continents Monitored Using ProView

2008/11/26  14:51 - Wincor Nixdorf's software ProView is used for the control and remote monitoring of self-service systems. With this product, the company has reached a milestone: more than 100,000 self-service devices in more than forty countries on all five continents are now administered and monitored with the help of this software.

MorphoSys Enters Therapeutic Research Collaboration on Novel Target Molecule with Genesis Research

2007/10/08  20:45 - MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime Standard Segment) today announced the signing of a research collaboration with New Zealand-based Genesis Research and Development Corporation Ltd. (New Zealand Stock Exchange: GEN).

IBA shares in Trading Halt During Roadshow to Raise Capital for Possible iSOFT Acquisition

2007/05/07  10:19 - IBA Health Limited (ASX: IBA) Australia's largest ASX listed healthcare information technology company has today requested, and been granted, a trading halt for its shares by the Australian Securities Exchange.

CyGenics' Subsidiary Signs Distribution Agreement with CombiMatrix

2005/11/30  09:13 - Leading cell therapy company CyGenics Limited (ASX: CYN) announced today that its wholly-owned subsidiary, Cell Sciences Ltd, has entered into a non-exclusive distribution agreement with CombiMatrix group of Acacia Research Corporation (Nasdaq: CBMX:ACTG), to distribute CombiMatrix products and services in Singapore.


     Biotech IT


Health & Pharm - Biotech IT

             

Site Search

 
 ENGLISH   All Languages

Science & Tech

 Science
 Space

Security

 Security General